跳至主要内容
临床试验/JPRN-jRCTs031180068
JPRN-jRCTs031180068已完成2 期

Dexamethasone for cancer-related fatigue in advanced cancer patients - multi-center phase II trial - Dex8mgPII

Miura Tomofumi0 个研究点目标入组 32 人开始时间: 2018年12月28日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
32

研究概览

简要总结

The efficacy and safety were evaluated by phase II clinical trial for advanced cancer patients receiving only palliative care and with moderate fatigue. The efficacy and safety were found. However, the efficacy did not achieve the preset outcomes.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • A diagnosis of advanced cancer (defined as metastatic or recurrent) with fatigue score 4 and more using NRS(0-10)
  • 20 years and older
  • Prognosis over 30 days
  • No anti-cancer treatment plan
  • Inpatient receiving palliative care
  • Performance status 1-3
  • Conprehension of Japanese
  • Provided written informed consent

排除标准

  • Patients received corticosteroid therapies within 1 week
  • Patients received surgery within 4 week
  • Patients received radiation therapy within 2 week
  • Patients received anti-tumor treatment within 2 week
  • Patients had diabetes mellitus, active infection and cognitive disorder

研究者

发起方
Miura Tomofumi

相似试验